Literature DB >> 2344056

Effects of isoflurane on conduction velocity and maximum rate of rise of action potential upstroke in guinea pig papillary muscles.

S Ozaki1, H Nakaya, Y Gotoh, M Azuma, O Kemmotsu, M Kanno.   

Abstract

This study was undertaken to determine whether isoflurane, a volatile anesthetic that is reported to possess a wide margin of cardiovascular safety, exerts electrophysiological effects on cardiac tissue. By use of standard microelectrode techniques, effects of isoflurane on the maximum rate of rise of action potential upstroke (Vmax) and conduction velocity were examined in guinea pig papillary muscles. Isoflurane decreased action potential amplitude and action potential duration in a concentration-dependent fashion. Isoflurane at 1.5 and 2.0 MAC decreased conduction velocity with as little influence on the maximum rate of rise of action potential upstroke as that exerted by halothane and enflurane. However, the effect of isoflurane in slowing intraventricular conduction was less than that of halothane and enflurane when compared at equi-MAC concentrations. Thus, isoflurane may be a safer anesthetic for the patients with intraventricular conduction abnormalities.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2344056     DOI: 10.1213/00000539-199006000-00007

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  2 in total

1.  Short latency activation of cortex during clinically effective subthalamic deep brain stimulation for Parkinson's disease.

Authors:  Harrison C Walker; He Huang; Christopher L Gonzalez; James E Bryant; Jeffrey Killen; Gary R Cutter; Robert C Knowlton; Erwin B Montgomery; Bart L Guthrie; Ray L Watts
Journal:  Mov Disord       Date:  2012-05-30       Impact factor: 10.338

2.  A key role for the subunit SUR2B in the preferential activation of vascular KATP channels by isoflurane.

Authors:  H Fujita; T Ogura; M Tamagawa; H Uemura; T Sato; A Ishida; M Imamaki; F Kimura; M Miyazaki; H Nakaya
Journal:  Br J Pharmacol       Date:  2006-09-25       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.